scispace - formally typeset
U

Ulrike Kulka

Researcher at Ludwig Maximilian University of Munich

Publications -  78
Citations -  2208

Ulrike Kulka is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Biodosimetry & Dosimetry. The author has an hindex of 24, co-authored 76 publications receiving 1815 citations.

Papers
More filters
Journal ArticleDOI

Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.

TL;DR: Endothelial cells seem to be most sensitive to combination of mTOR inhibition and radiotherapy, and the combination of radiotherapy and antiangiogenic therapy with mTOR inhibitor RAD001 (Everolimus) might exert additive/synergistic effects on tumor growth.